Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

528
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
528
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

719
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
719
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

659
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
659
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

657
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
657
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

317
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
317
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

753
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
753

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing real-world data gaps: estimating the uk population cost of crohn's disease and ulcerative colitis using a flexible cost-of-illness model informed by the optimal patient journey and IBDUK patient survey 2023.

BMC health services research·2026
Same author

Learning disability register enrolment in young people in England: Cohort Study, 2015-2023.

The British journal of general practice : the journal of the Royal College of General Practitioners·2026
Same author

Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial.

BMJ open gastroenterology·2026
Same author

Genome-wide genetic overlap between fear-based disorders and generalised anxiety disorder.

Molecular psychiatry·2026
Same author

Accelerometer-measured postoperative physical activity confers a significant mortality benefit following joint arthroplasty.

Bone & joint research·2026
Same author

Sleep and Activity Patterns in Depression From Wearable Data: Unsupervised Clustering Study.

Journal of medical Internet research·2026

Related Experiment Video

Updated: Dec 3, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.4K

Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case-control

Jonathan Blackwell1, Sonia Saxena2, Irene Petersen3,4

  • 1Gastroenterology, St George's University of London, London, UK.

Gut
|October 28, 2020
PubMed
Summary

Depression preceding gastrointestinal symptoms increases the risk of developing inflammatory bowel disease (IBD). However, depression without prior GI symptoms does not appear to be a risk factor for IBD.

Keywords:
crohn's diseaseinflammatory bowel diseasepsychophysiologypsychosomatic medicineulcerative colitis

More Related Videos

Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

68.3K
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

212

Related Experiment Videos

Last Updated: Dec 3, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.4K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

68.3K
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

212

Area of Science:

  • Gastroenterology
  • Psychiatry
  • Epidemiology

Background:

  • Depression is a recognized mental health condition.
  • Inflammatory bowel disease (IBD) encompasses chronic conditions like ulcerative colitis (UC) and Crohn's disease (CD).
  • A potential link between depression and IBD development has been suggested, possibly due to overlapping gastrointestinal (GI) symptoms.

Purpose of the Study:

  • To investigate the association between depression and the subsequent development of IBD.
  • To determine if pre-existing GI symptoms modify the relationship between depression and IBD risk.
  • To differentiate the risk of IBD in individuals with depression accompanied by GI symptoms versus those with depression alone.

Main Methods:

  • A nested case-control study was conducted using the Clinical Practice Research Datalink.
  • Incident cases of UC and CD were identified between 1998 and 2016, with matched controls.
  • Depression exposure was assessed 4.5-5.5 years prior to IBD diagnosis, with subgroups created based on the presence of GI symptoms before depression onset.

Main Results:

  • A higher prevalence of depression was observed 5 years before IBD diagnosis in both UC and CD cases compared to controls.
  • Individuals with depression and preceding GI symptoms showed significantly increased adjusted risks for developing UC (OR 1.47) and CD (OR 1.41).
  • Depression occurring in the absence of prior GI symptoms was not significantly associated with an increased risk of UC or CD.

Conclusions:

  • Depression accompanied by gastrointestinal symptoms warrants further investigation for potential IBD.
  • Depression as an isolated factor, without preceding GI symptoms, does not appear to elevate the risk for developing IBD.
  • These findings highlight the importance of considering GI symptom history when evaluating the link between mental health and IBD.